1. Alle Produkte
8 Produkte 
8 Produkte 
Finden Sie Ihr Produkt

8 Produkte 
3M Tegaderm Antimicrobial Dressing

3M™ Tegaderm™ CHG Antimicrobial I.V. Site Dressings

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressings provide antimicrobial protection, site visibility, catheter securement, and moisture management all in a single product to help meet your goals for patient safety, clinician confidence, and cost of care.

Featured Videos

  • 3M Tegaderm CHG IV Dressings

    Antimicrobial Protection

    3M™ Tegaderm™ CHG I.V. dressing is now proven and indicated to reduce Catheter-related bloodstream infections (CRBSIs) and catheter colonisation. Thus the only transparent I.V. dressing with this indication.

    It is an all-in-one antimicrobial transparent film dressing, providing comfort with exceptional securement whilst supporting I.V. site care best practices and protocols.
    The transparent film of Tegaderm™ CHG Dressings provides a barrier to contaminants including liquids, viruses*, and a broad range of bacteria and yeast commonly associated with CRBSIs. The 3M™ Tegaderm™ CHG Dressing features a transparent antimicrobial CHG gel pad that conforms around the catheter to deliver immediate and continuous protection against skin flora.

    * In vitro testing shows that the transparent film of 3M™ Tegaderm™ CHG Dressings provides a viral barrier from viruses 27 nm in diameter or larger while the dressing remains intact without leakage.

  • Tegaderm transparent film

    Transparent to Allow Continuous Site Monitoring

    The transparent film and transparent, antimicrobial CHG gel pad allow continuous monitoring for early signs of infection. The gel pad remains clear and protects even in the presence of blood, saline, and exudate.

    Intravascular catheters are associated with a number of risks, including phlebitis, infiltration, extravasation, thrombosis, thrombophlebitis, and infection.  The density of skin flora at the catheter insertion site is a major risk factor. It is estimated that up to 60% of CRBSI originate from the patient’s skin flora.** Ensuring continuous catheter site visibility, to identify potential complications, is critically important.

    Infusion Nursing Standards of Practice specify that I.V. sites must be visible at all times. Any dressing material that may obstruct visualisation of the catheter-skin junction should not be used.5

    The CDC recommends the use of transparent film dressings for I.V. site care because they reliably secure the device, permit continuous visual inspection of the catheter site and require less frequent changes than standard gauze and tape dressings do, saving time for care givers.

    ** 3M™ Tegaderm™ CHG Dressing is not intended to treat catheter-related blood stream infections (CRBSI) or other percutaneous device-related infections and has not been studied in a randomized clinical study as to its effectiveness in preventing such infections.

  • Footnotes

    1. Maki DG. A Novel Integrated Chlorhexidine-Impregnated Transparent Dressing for Prevention of Vascular Catheter-related Bloodstream Infection: A Prospective Comparitive Study in Healthy Volunteers. SHEA, April 2008.

    2. Bashir MH, et al. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. American Journal of Infection Control (AJIC), 2012; 40(4):344-8.

    3. Eyberg C. A Controlled Randomized Prospecitve Comparative Study to Evaluate the Ease of Use of a Transparent Chlorhexidine Impregnated Gel Dressing Versus a Chlorhexidine Disk in Health Volunteers. Journal of the Association for Vascular Access (JAVA), Fall 2008 Vol. 13 No. 3.

    4.Kohan, Cynthia MT, MS, CIC; Boyce, John MD. Poster "A Different Experience with Two Chlorhexidine Gluconate Dressings for Use on Central Venous Devices." APIC, Ft. Lauderdale FL, June 2013.

    5. Infusion Nursing Standards of Practice, Jan/Feb 2011 Vol 34, 1S ISSN 1533-1458.

    6. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-related Infections. Healthcare Infection Control Practices Advisory Committee (HICPAC); (Appendix 1). Clin Infect Dis. 2011;52(9):e162.

 1-8 von 8 gefundene Produkte
Vergleichen Sie bis zu drei Produkte: